NCT07711756

Brief Summary

This study was initiated because of the limited litterature available on this topic. The objective was to compare adherence to antibiotic therapy among a pediatric population treated in two healthcare settings in France: the Gignac Health Center, a primary care facility, and the Pediatric Emergency Department of Montpellier University Hospital. This observational study assessed treatment adherence through a telephone questionnaire administered to parents after the theorical end of the treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

1.9 years

First QC Date

July 13, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

compliance - antibiotic - pediatric

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients who adhered to the antibiotic prescription provided by the general practitioner (GP) or the emergency physician (University Hospital)

    Treatment adherence was considered satisfactory when at least 80% of the prescribed antibiotic course was taken

    The study period extended from the initial consultation (antibiotic prescription) to 21 days after the prescription, depending on the prescribed treatment duration.

Study Arms (2)

Pediatric patients prescribed antibiotic for acute bacterial infection at the Gignac Health center

Pediatric patients aged 3 months to 16 years presenting with an acute bacterial infection and prescribed an outpatient antibiotic treatment were eligible for inclusion. Parents were contacted by telephone between 15 and 21 days after the antibiotic prescription to assess treatment adherence.

Children prescribed antibiotic for acute bacterial infection at pediatric emergency of Montpellier

Pediatric patients aged 3 months to 16 years presenting with an acute bacterial infection at pediatric emergency department Montpellier University Hospital and prescribed an outpatient antibiotic treatment were eligible for inclusion. Parents were contacted by telephone between 15 and 21 days after the antibiotic prescription to assess treatment adherence.

Eligibility Criteria

Age3 Months - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients presenting to the Gignac Primary Care Health Center or the Pediatric Emergency Department of Montpellier University Hospital with a suspected bacterial infection and considered eligible for an outpatient oral antibiotic prescription.

You may qualify if:

  • Children aged 3 months to 16 years
  • Receiving an outpatient oral antibiotic prescription
  • Diagnosed with an acute bacterial infection

You may not qualify if:

  • Unemancipated minors presenting without a parent or legal guardian.
  • Refusal to participate after the reflection period
  • Parents unable to understand the study information (e.g., language barrier or cognitive impairment)
  • Not affiliated with, or not a beneficiary of, a national health insurance scheme
  • Pregnant or breastfeeding female participants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pneumonia, BacterialOtitis MediaPneumonia, MycoplasmaImpetigo

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesOtitisEar DiseasesOtorhinolaryngologic DiseasesMycoplasma InfectionsMycoplasmatales InfectionsGram-Negative Bacterial InfectionsStaphylococcal Skin InfectionsStaphylococcal InfectionsGram-Positive Bacterial InfectionsStreptococcal InfectionsSkin Diseases, BacterialSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Eric E JEZIORSKI, Professor of Medicine at Montp

    Pediatric Emergency Department, Montpellier University Hospital

    STUDY DIRECTOR

Central Study Contacts

Eric E JEZIORSKI, Professor of Medicine

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2026

First Posted

July 17, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share